Mustang Bio, Inc. MBIO 深 滬
已收盤 04-02 16:00:00 美东时间
0.775
+0.015
+1.96%
華盛通- 最 高0.79
- 今 開0.7426
- 成交量 5.66万股
- 最 低 0.74
- 昨 收 0.7601
- 總市值 587.25万
- 52周最高 7.00
- 市盈率 靜 --
- 換手率 0.75%
- 52周最低 0.5306
- 委 比 3.47%
- 總股本 757.75万
- 歷史最高 10012.50
- 量 比 2.00
- 振 幅 6.58%
- 歷史最低 0.5306
- 每 手 1
- 風險率 0.39%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Mustang Bio Shareholders Approve Equity Plans and Directors
The latest announcement is out from Mustang Bio ( ($MBIO) ). At its 2025 Annual...
2025-12-24 05:45
Mustang Bio Inc. Announces Date for Upcoming Annual Stockholder Meeting
Mustang Bio Inc. will hold its Annual Meeting of Stockholders virtually on December 22, 2025. During the meeting, stockholders will be asked to vote on the election of seven directors for a term of on...
2025-12-04 05:06
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Sonnet BioTherapeutics (NASDAQ:SONN) shares rose 239.4% to $17.55 dur...
2025-07-14 20:08
Calidi Biotherapeutics Stock Jumps 39% After Hours — What's Going On
Calidi Biotherapeutics (NYSE: CLDI) surged 39.47% after hours Tuesday, following renewed investor interest in its innovative cancer treatment developments.
2025-07-09 12:09
ADVISORY-Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
July 8 (Reuters) - An alert on the global oncology market experiencing substantial growth from an FN Media Group commentary tagged to Mustang Bio MBIO.O, Verastem Oncology VSTM.O, AstraZeneca AZN.L, O...
2025-07-08 21:26
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Mustang Bio (NASDAQ:MBIO) stock increased by 217.6% to $3.78 during Mo...
2025-07-08 01:06
BUZZ-Mustang soars on FDA's orphan drug tag for brain cancer therapy
** Shares of cancer therapy developer Mustang Bio MBIO.O rise 234% to over 5-month high of $3.97 ** Stock set for its best day in over a year, if gains hold ** Co says it received 'orphan drug designa...
2025-07-08 00:39
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma
Mustang Bio's MB-101 CAR-T cell therapy received FDA Orphan Drug Designation for treating recurrent diffuse and anaplastic astrocytoma and glioblastoma. The designation supports the company's strategy to combine MB-101 with MB-108, an oncolytic virus, to enhance efficacy by reshaping the tumor microenvironment. Early data show promising results, including complete responses lasting over 66 months.
2025-07-07 12:30
BUZZ-U.S. STOCKS ON THE MOVE-Tesla, ABM Industries, Regeneron
Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stocks nudged lower on Wednes...
2025-07-02 23:50
Why Greenbrier Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
Shares of The Greenbrier Companies, Inc. (NYSE: GBX) rose sharply in today's pre-market trading after the company posted stronger-than-expected results for the third quarter. The company posted quarterly earnings of $1.86 per share, beating market estimates of 98 cents per share.
2025-07-02 17:55
